Similar observations are seen in clinical studies where FMT increased insulin sensitivity in patients with metabolic syndrome and increased haemoglobin in those with anaemia caused by chronic disease by modulating the intestinal microbiota composition and metabolism [47, 48]. This evidence concerns the gene INS and anemia (phenotype).